Skip to main content
Erschienen in: BMC Psychiatry 1/2023

Open Access 01.12.2023 | Research

Absconding among admitted patients with bipolar affective disorder diagnosis in Uganda

verfasst von: Joan Abaatyo, Alain Favina, Mark Mohan Kaggwa

Erschienen in: BMC Psychiatry | Ausgabe 1/2023

Abstract

Background

Hospitalization is often necessary for individuals with Bipolar affective Disorder (BAD) during severe manic or depressive episodes, as well as for stabilizing treatment regimens. However, a significant proportion of patients admitted for treatment of BAD abscond or leave the hospital without permission during their stay. In addition, patients managed for BAD may have unique characteristics that might force them into absconding. For example, the high prevalence of co-morbid substance use disorder – craving to use substances, suicidal behaviors – attempts to die by suicide, and cluster B personality disorders – characterized by impulsive acts. It is, therefore, essential to understand the factors contributing to absconding among patients with BAD, to facilitate designing strategies for preventing and managing this behavior.

Method

This study was based on a retrospective chart review of the inpatients diagnosed with BAD at a tertiary psychiatry facility in Uganda from January 2018 to December 2021.

Results

Approximately 7.8% of those with BAD absconded from the hospital. The likelihood of absconding among those with BAD increased with the use of cannabis [adjusted odds ratio (aOR) = 4.00, 95% confidence interval (CI) = 1.22–13.09, p-value = 0.022] and having mood lability [aOR = 2.15, 95% CI = 1.10–4.21, p-value = 0.025]. However, receiving psychotherapy during the admission (aOR = 0.44, 95 CI = 0.26–0.74, p-value = 0.002) and treatment with haloperidol (aOR = 0.39, 95% CI = 0.18–0.83, p-value = 0.014) reduced the likelihood of absconding.

Conclusion

Absconding among patients with BAD is common in Uganda. Those with symptoms of affective lability and those with comorbid cannabis use tend to abscond more, while those who receive haloperidol and psychotherapy are less likely to abscond.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Bipolar affective disorder (BAD) is a chronic mental health condition characterized by episodes of mania and depression. Hospitalization is often necessary for individuals with BAD during severe manic or depressive episodes, as well as for stabilizing treatment regimens [1]. However, a significant proportion of patients admitted for treatment of bipolar disorder abscond or leave the hospital without permission during their stay [2].
Absconding can have severe consequences for the patient, including worsening their condition and an increased risk of harm to themselves or others [36]. For example, exposure to violence, suicide, homicide, poor control of symptoms, loss of contact and confidence with psychiatric services, and potential legal liability for the hospital [3, 4]. In addition to the above effects of absconding, high suicide rates between 20% and 30% of patients have been reported [7, 8]. While most absconds slip away with no harm caused, and return by themselves, usually within 24 h, they still cause the staff an enormous amount of anxiety [9, 10]. Additionally, the confidence of the relatives of the absconds can be severely damaged [11].
The phenomenon of absconding has been associated with various predictors, which include younger age, male sex, single status, shorter length of hospital stays, personality disorders, substance use disorders, patients who have been referred to the psychiatric hospital by police, those who are unemployed [1214]. Various clinical factors have also been associated with absconds, for example, a history of absconding behaviors, substance misuse, or dependence [6]. A history of non-compliance with treatment, a history of sexually inappropriate behavior, and a history of childhood conduct problems and current symptom presentation including pacing, appearing to be hyper-vigilant, severely distressed, agitated, tormented, expressing suicidal ideation, or simply requesting go to the shops [3]. Other predictive factors include the patient’s level of functioning and ability to comprehend, understand and comply with the admission process [3]. Patients managed for BAD may have special characteristics that might force them into absconding such as impulsive acts. It is therefore important to understand the factors contributing to absconding among patients with BAD, to facilitate designing strategies for preventing and managing this behavior.
This study provides a different lens to the literature since most previous studies about absconding have focused on Schizophrenia, forensic patients, or psychiatric patients in general [9, 15, 16]. In addition, the study was conducted in Africa, where the annual rate of absconding from psychiatry units is highest; for example, In Uganda alone, about 10 to 50 patients are estimated to abscond every month [1719].

Methods

This study was based on a retrospective chart review of the inpatient diagnosed with BAD at a tertiary psychiatry facility in Uganda from January 2018 to December 2021. Retrospective chart reviews have previously been used to understand various mental health conditions in the country [2022]. Based on their diagnosis, the patients were identified from a database of all patients admitted at Mbarara Regional Referral Hospital psychiatry unit between 2018 and 2021. Census sampling method was used in which all files of patients with BAD admitted from January 2018 and December 2021. No file was excluded since all files had captured age and gender. The formal consent for the data of the included patients was waivered by the Mbarara University of Science and Technology Research Ethics Committee since the data was retrospective and we could not trace all involved participants (Ethical approval number: MUSTREC-2021-229). However, the following information was captured for this study (i) age, (ii) gender, (iii) substances of addiction used, (iv) clinical symptoms, (v) abscondment or discharge from ward, (vi) diagnosis, (vii) family history of mental illness, (viii) employment status, (ix) number of days with symptoms before admission, and (x) number of days on the ward.

Data analysis

Data were analyzed using STATA version 15.0. Categorical variables were presented with frequencies and percentages. The Gaussian assumption was used to assess normality based on the Shapiro-Wilks test and histograms. Skewed continuous variables were presented in median and interquartile ranges. Chi-square tests for categorical variables or rank sum tests for continuous variables were performed to determine significant differences between individuals with a diagnosis of BAD who absconded from the hospital and those who did not. Statistical significance values were included in logistic regression analysis using absconding as the dependent variable. Factors significant at bivariate logistic analysis were tested for collinearity using variance inflation factors (VIF). Those with a VIF below two were included in the final model at multiple logistic regression. The significant level was at less than 5% for a 95% confidence interval.

Results

A total of 3104 records were retrieved. Of these, 1,068 had a diagnosis of BAD, with 83 (7.8%) having absconded from the hospital. Absconding was statistically more among those who did not receive psychotherapy than those who received (10.4% vs. 4.6%, X2 = 12.78, p < 0.001). Those who absconded had statistically fewer days on ward than those who did not, i.e., median of 4 vs. 7, respectively, p < 0.001. More participants with mood lability absconded than those without (13.2% vs. 7.3%, X2 = 4.06, p-value 0.044). More participants who used cannabis absconded than those who did not (25% vs. 7.5%, X2 = 6.71, p-value 0.010). Fewer participants who had irritability absconded compared to those who did not (3.5% vs. 8.4%, X2 = 4.30, p-value 0.038). Fewer participants were treated with haloperidol absconded than those who did not (3.6% vs. 8.8%, X2 = 6.45, p-value 0.011). Table 1.
Table 1
Participant characteristics distribution across absconding from hospital among patients with Bipolar Affective Disorder
Variable
Escape
X2 (p-value)
No (985/ 92.3%)
Yes (83/ 7.8%)
Age (median, IQR)
29 (23–40)
29 (24–38)
(0.922)
Marital status
 Divorced
11 (91.7)
1 (8.3)
1.20 (0.878)
 Married
366 (94.3)
22 (5.7)
 Separated
61 (92.4)
5 (7.6)
 Single
345 (92.5)
28 (7.5)
 Widowed
25 (92.6)
2 (7.4)
Gender
 Female
506 (93.7)
34 (6.3)
3.38 (0.066)
 Male
477 (90.7)
49 (9.3)
Employment status
 Unemployed
652 (91.8)
58 (8.2)
0.03 (0.873)
 Employed
119 (92.3)
10 (7.7)
Positive family history of mental illness
 No
765 (92.6)
61 (7.4)
0.41 (0.520)
 Yes
211 (91.3)
20 (8.7)
Clinical presentation
1. Hallucinations
 
 No
771 (92.0)
67 (8.0)
0.25 (0.614)
 Yes
213 (93.0)
16 (7.0)
2. Delusions
 
 No
837 (92.4)
69 (7.6)
0.22 (0.637)
 Yes
147 (91.3)
14 (8.7)
3. Uncoordinated speech
 
 No
749 (92.5)
61 (7.5)
0.29 (0.591)
 Yes
235 (91.4)
22 (8.6)
4. Suspiciousness
 
 No
938 (92.2)
79 (7.8)
0.00 (0.952)
 Yes
46 (92.0)
4 (8.0)
5. Poor sleep
 
 No
342 (90.5)
36 (9.5)
2.49 (0.115)
 Yes
642 (93.2)
47 (6.8)
6. Aggression
 
 No
493 (93.2)
36 (6.8)
1.39 (0.239)
 Yes
491 (91.3)
47 (8.7)
7. Food refusal
   
 No
902 (91.8)
81 (8.2)
3.70 (0.054)
 Yes
82 (97.6)
2 (2.4)
8. Affective lability
   
 No
905 (92.7)
71 (7.3)
4.06 (0.044)
 Yes
79 (86.8)
12 (13.2)
9. Talking to self
   
 No
902 (92.2)
76 (7.8)
0.00 (0.975)
 Yes
82 (92.1)
7 (7.9)
10. Restlessness
   
 No
634 (91.7)
57 (8.3)
0.604 (0.437)
 Yes
350 (93.1)
26 (6.9)
11. Neglect of body hygiene
   
 No
890 (92.5)
72 (7.5)
1.18 (0.277)
 Yes
94 (89.5)
11 (10.5)
12. Destructiveness
   
 No
790 (92.8)
61 (7.2)
2.19 (0.139)
 Yes
194 (89.8)
22 (10.2)
13. Singing
   
 No
906 (92.3)
76 (7.7)
0.03 (0.870)
 Yes
78 (91.8)
7 (8.2)
14. Prayerfulness/ religiosity
   
 No
929 (92.2)
79 (7.8)
0.09 (0.768)
 Yes
55 (93.2)
4 (6.8)
15. Excessive energy
   
 No
681 (92.0)
59 (8.0)
0.13 (0.722)
 Yes
303 (92.7)
24 (7.3)
16. Wandering away from home
   
 No
748 (92.8)
58 (7.2)
1.56 (0.212)
 Yes
236 (90.4)
25 (9.6)
17. Talkativeness
   
 No
366 (92.9)
28 (7.1)
0.39 (0.530)
 Yes
618 (91.8)
55 (8.2)
18. Social withdrawal
   
 No
954 (92.1)
82 (7.9)
0.92 (0.337)
 Yes
30 (96.8)
1 (3.2)
19. Suicidal ideations
   
 No
954 (92.1)
82 (7.9)
0.92 (0.337)
 Yes
30 (96.8)
1 (3.2)
20. Grandiosity
   
 No
892 (92.2)
75 (7.8)
0.01 (0.931)
 Yes
92 (92.0)
8 (8.0)
21. Thoughtlessness
   
 No
975 (92.2)
83 (7.8)
0.77 (0.382)
 Yes
9 (100)
-
22. Poor appetite
   
 No
915 (92.0)
80 (8.0)
1.40 (0.236)
 Yes
69 (95.8)
3 (4.2)
23. Undressing
   
 No
927 (92.6)
74 (7.4)
3.36 (0.067)
 Yes
57 (86.4)
9 (13.6)
24. Irritability
   
 No
845 (91.6)
78 (8.4)
4.30 (0.038)
 Yes
139 (96.5)
5 (3.5)
25. Disorganized behavior
   
 No
927 (92.1)
80 (7.9)
0.68 (0.408)
 Yes
57 (95.0)
3 (5.0)
Current comorbid substance use
   
1. Use of Cannabis
   
 No
972 (92.5)
79 (7.5)
6.71 (0.010)
 Yes
12 (75.0)
4 (25.0)
 
2. Use of alcohol
   
 No
977 (92.3)
82 (7.7)
0.14 (0.707)
 Yes
8 (88.9)
1 (11.1)
 
3. Multiple substance use
   
 No
974 (92.2)
82 (7.8)
0.03 (0.870)
 Yes
10 (90.9)
1 (9.1)
 
Days with symptoms before admission (median, IQR)
7 (3–14)
7 (4–14)
(0.3592)
Days of admission (median, IQR)
7 (4–12)
4 (2–9)
(< 0.001)
Current in-patient treatment
Psychotherapy
   
 No
522 (89.5)
61 (10.4)
12.78 (< 0.001)
 Yes
460 (95.4)
22 (4.6)
Chlorpromazine
   
 No
117 (95.9)
5 (4.1)
2.55 (0.110)
 Yes
850 (91.8)
76 (8.2)
Haloperidol
   
 No
756 (91.2)
73 (8.8)
6.45 (0.011)
 Yes
211 (96.4)
8 (3.6)
Risperidone
   
 No
946 (92.1)
81 (7.9)
1.79 (0.180)
 Yes
21 (100)
-
Olanzapine
   
 No
964 (92.3)
80 (7.7)
1.68 (0.195)
 Yes
3 (75.0)
1 (25.0)
Trifluoperazine
   
 No
940 (92.3)
79 (7.8)
0.03 (0.865)
 Yes
27 (93.1)
2 (6.9)
Fluphenazine
   
 No
874 (92.1)
75 (7.9)
0.43 (0.514)
 Yes
93 (93.9)
6 (6.1)
Quetiapine
   
 No
958 (92.3)
80 (7.7)
0.07 (0.787)
 Yes
9 (90.0)
1 (10.0)
Carbamazepine
   
 No
43 (91.5)
4 (8.5)
0.04 (0.846)
 Yes
776 (92.3)
65 (7.7)
Lithium
   
 No
812 (92.3)
68 (7.7)
0.25 (0.616)
 Yes
7 (87.5)
1 (12.5)
Sodium valproate
   
 No
767 (92.1)
66 (7.9)
0.44 (0.508)
 Yes
52 (94.5)
3 (5.5)

Factors associated with absconding from the hospital

The values significant at inferential statistics, i.e., chi-square and rank sum test, were included in logistic analysis. All variables with a p-value of less than 0.2 were tested for collinearity before being included in the final model. The likelihood of absconding among those with BAD increased with current use of cannabis [adjusted odds ratio (aOR) = 4.00, 95% confidence interval (CI) = 1.22–13.09, p-value = 0.022] and having mood lability [aOR = 2.15, 95 CI = 1.10–4.21, p-value = 0.025]. However, having psychotherapy (aOR = 0.44, 95 CI = 0.26–0.74, p-value = 0.002) and treatment with haloperidol (aOR = 0.39, 95% CI = 0.18–0.83, p-value = 0.014) reduced the likelihood of absconding. Table 2.
Table 2
Logistic analysis for factors associated with absconding from hospital among patients with Bipolar Affective Disorder
Variable
Bi variable analysis
Multivariable analysis
Crude Odds ratio (95% confidence interval)
p-value
Adjusted odds ratio (95% confidence interval)
P-value
Number of days admitted
0.99 (0.97–1.02)
0.724
-
 
Affective lability
 No
1 (reference)
 
1 (reference)
 
 Yes
1.94 (0.01–3.72)
0.048
2.15 (1.10–4.21)
0.025
Current comorbid use of cannabis
 No
1 (reference)
 
1 (reference)
 
 Yes
4.10 (1.29–13.01)
0.017
4.00 (1.22–13.09)
0.022
Irritability
    
 No
1 (reference)
 
1 (reference)
 
 Yes
0.039 (0.16–0.98)
0.045
0.38 (0.13–1.06)
0.064
Psychotherapy
    
 No
1 (reference)
 
1 (reference)
 
 Yes
0.41 (0.25–0.68)
0.001
0.44 (0.26–0.74)
0.002
In-patient Haloperidol treatment
    
 No
1 (reference)
 
1 (reference)
 
 Yes
0.39 (0.19–0.83)
0.014
0.39 (0.18–0.83)
0.014

Discussion

The study aimed determine the prevalence and associated factors of absconding from the hospital following admission among individuals with BAD using a retrospective chart review of the inpatient from January 2018 to December 2021 at Mbarara Regional Referral psychiatry ward.
The prevalence of absconding across the entire study period was 7.8%, a percentage similar to that found among psychiatric patients of various diagnoses in South Africa of 7.83 [19]. However, the prevalence observed in this study was much lower than that of 45.4% seen among participants with BAD in a two months prospective study in India [16]. This difference could be due to the significant difference in the study duration, study design, study setting and probably because the study by Khisty et al. (2008) had a small overall sample size of participants with BAD of 63 [16]. Similarly, the prevalence observed in this study was lower than that of 21.4% among those with BAD in a one year prospective study in Iran [23]. This difference could also be due to the significant difference in the study duration, study design, study setting and probably because the study by Sheikhmoonesi et al. (2012) had a small overall sample size of participants with BAD of 12 [23].
The likelihood of absconding increased with having affective lability, a finding congruent with that of Andoh et al. (2004), who discovered that having a very labile mood is strong associated with absconding from mental health facilities [24]. Patients with affective lability are most likely have exaggerated impairments in inhibitory control due to exaggerated activation in several regions of the Prefrontal cortex (PFC) as well as the anterior cingulate gyrus and caudate by the over stimulated amygdala from excess serotonin to this region [2527]. This makes them prone to making impulsive decisions such as absconding. Additionally, affective lability is associated with greater severity in the clinical expression of BAD with more frequent comorbidities of anxiety disorders and substance use disorders [28], that are likely to cause impairment in decision making. It is possible that patients with affective lability may abscond from hospitals due to other factors, including a lack of understanding of their condition, frustration with the hospital environment or treatment, or a desire to escape from the perceived constraints or structure of the hospital setting [18].
Comorbid use of cannabis among participants with BAD increased the likelihood of absconding. This finding was congruent with that by Wilkie et al. (2014) who reported that comorbid substance use almost triples the odds of absconding among forensic patients [29]. The explanation for this finding is most likely because substances like cannabis use causes brain atrophy impairing one’s cognition and executive functioning [30], worsening decision-making, increasing impulsive acts, and further complicating the course of BAD with a worsening prognosis [31]. In addition, the following reasons may lead to the increased likelihood of absconding of patients with BAD who use cannabis. (i) Lack of understanding: Some people may not fully understand the risks associated with using cannabis while receiving treatment for a mental health condition like bipolar disorder. They may feel that the cannabis is helping them feel better and are unaware of the potential negative effects on their treatment. (ii) Relief of symptoms: Cannabis can potentially help to reduce anxiety and improve mood [3234], which may make someone feel better in the short term. This could lead them to believe that they no longer need treatment and they may abscond from the hospital. (iii) Difficulty with treatment: Being in a hospital can be overwhelming and stressful, particularly if someone is not used to being in a hospital setting [35]. This stress, combined with the symptoms of bipolar disorder, could make someone feel like they want to leave and find relief elsewhere, potentially leading to absconding. It is important to emphasize to patients not to use cannabis while receiving treatment for bipolar disorder, as it can interfere with the effectiveness of treatment and potentially worsen symptoms in the long term [3638].
Having a current in-patient treatment with haloperidol was protective against absconding in participants with BAD. This finding is congruent with studies that point out the protective role of haloperidol in challenging behavior, an example of which is absconding, among mental illness patients [39, 40]. This is likely because manic symptoms of BAD, like excitation, irritability, and elevated mood, which are more likely to increase absconding tendencies, are possibly due to elevated levels of extracellular Dopamine (DA) in areas receiving dopaminergic innervation, with the consequent activation of DA receptors [4143]. Haloperidol is a high-potent DA antagonist [44], alleviating manic symptoms of BAD. In addition, haloperidol, compared to other antipsychotics in the present study is associated with more extrapyramidal side effects associated with disturbances in mobility and motivation [45], which could interfere with the desire to abscond. However, the present study did not capture information regarding the dosage, route of administration, and frequent of use, that may influence the pharmacodynamics of the medications.
Psychotherapy was also protective against absconding. This finding is congruent with various studies that state the role of psychotherapy in alleviating absconding among those with mental illness [3, 46, 47]. This is likely because the first step of the intervention involving effective educational interventions of psychotherapy, like description of the problem to be treated, its causes if known, and the methods of intervention to be used to alleviate the problem, is a predictor of better outcomes of interventions for psychiatric disorders [48]. This can make them feel more in control of their lives and more able to cope with their challenges. Psychotherapy can also provide a safe and supportive environment where individuals can discuss their thoughts and feelings without fear of judgment [49, 50]. This can help them feel more connected and less isolated, which may reduce the likelihood of them wanting to leave treatment. In addition, psychotherapy can help individuals develop healthy coping skills and strategies for managing their symptoms [50, 51]. This can improve their overall well-being and reduce the need for hospitalization or other forms of treatment. It is important to note that psychotherapy is just one part of a comprehensive treatment plan for bipolar disorder and may be used in combination with medication and other therapies. With multiple factors involved in absconding, holistic modalities and care plans should be emphasized in dealing with absconding.

Limitations

This study’s findings should be interpreted with caution in view of the following limitations. First, this was a retrospective chart review, and missing data are not uncommon in such study designs. To overcome this issue, we recommend future researchers to make provisions for multiple assessment methods, such as prospective study designs. Second, absconding was reported in the participant’s charts by nurses who are less likely to report those missing if risks involved are perceived as very low or absconded after they were observed as recovered. We recommend the using standard operational criteria to prevent absconding. In addition, the symptoms reported such as irritability, affective lability, and among others, were based on information captured by the experienced clinicians at the psychiatric facility. We recommend the use of clinically validated tools to measure and capture symptoms in future studies. Thirdly, many variables that could have influenced the findings, such as time of the day when participants absconded and financial constraints as regards to feeding and medication unavailability on ward, as previously described by Kaggwa et al. (2021) [18]; were not retrieved from the records of patients and hence not included in the analysis. We recommend future studies to use prospective study designs to capture such information. Our study did not specify the type of psychotherapy that was effective in reducing absconding. We recommend future researchers to investigate the different psychotherapies for better recommendations. Also, the sample size of the study was small, and this may not be statistically powered enough. We recommend large sample studies involving multiple sites to ensure generalizability and statistical accuracy. Finally, the data included in the analysis were from one facility, limiting the generalization of the findings throughout the country. Although the sample of patients with BAD in our study cannot be said to be representative of Uganda as a whole, it could be assumed that the estimate could have been higher considering that among those who receive orthodox clinical attention, only a fraction come to tertiary health facilities where the present study was conducted. Some patients may have presented to primary health facilities, secondary health facilities or other private health facilities.

Conclusions

In this retrospective review of cases of absconding among those with BAD over a four-year period in Uganda, it can be concluded that absconding among patients with BAD is common in Uganda. Those with symptoms of affective lability and those with comorbid cannabis use tend to abscond more while those who receive haloperidol and psychotherapy are less likely to abscond. Further studies looking at absconding among those with BAD and other psychiatric conditions using a prospective approach are warranted to provide extended causal relationships and management strategies.

Acknowledgements

The authors acknowledge the support of the Department of Psychiatry Mbarara Regional Referral Hospital.

Declarations

The present study was conducted in accordance with the Declaration of Helsinki 2013. The study was approved by Mbarara University of Science and Technology Research Ethics Committee (Approval number: MUST-2021-229) and provided a waiver of consent for study participants. All of the participants information were anonymously presented in this study.
Not applicable.

Conflicting interests

No conflicts of interests among authors.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Leahy RL. Bipolar disorder: Causes, contexts, and treatments. In., vol. 63: Wiley Online Library; 2007: 417–424. Leahy RL. Bipolar disorder: Causes, contexts, and treatments. In., vol. 63: Wiley Online Library; 2007: 417–424.
2.
Zurück zum Zitat Carr VJ, Lewin TJ, Sly KA, Conrad AM, Tirupati S, Cohen M, Ward PB, Coombs T. Adverse incidents in acute psychiatric inpatient units: rates, correlates and pressures. Aust N Z J Psychiatry. 2008;42(4):267–82.CrossRefPubMed Carr VJ, Lewin TJ, Sly KA, Conrad AM, Tirupati S, Cohen M, Ward PB, Coombs T. Adverse incidents in acute psychiatric inpatient units: rates, correlates and pressures. Aust N Z J Psychiatry. 2008;42(4):267–82.CrossRefPubMed
3.
Zurück zum Zitat Grotto J, Gerace A, O’Kane D, Simpson A, Oster C, Muir-Cochrane E. Risk assessment and absconding: perceptions, understandings and responses of mental health nurses. J Clin Nurs. 2015;24(5–6):855–65.CrossRefPubMed Grotto J, Gerace A, O’Kane D, Simpson A, Oster C, Muir-Cochrane E. Risk assessment and absconding: perceptions, understandings and responses of mental health nurses. J Clin Nurs. 2015;24(5–6):855–65.CrossRefPubMed
4.
Zurück zum Zitat Andoh B. The consequences of absconding from mental hospitals. Mountbatten J Legal Stud. 1998;2(1):70–92. Andoh B. The consequences of absconding from mental hospitals. Mountbatten J Legal Stud. 1998;2(1):70–92.
5.
Zurück zum Zitat Anisi S, Zarei E, Kariman H, Kazemi MK, Chehrazi M. Patient absconding and its predictors: a 5-year retrospective analysis in a general teaching Hospital in Tehran, Iran. Shiraz E-Medical Journal 2017, 18(12). Anisi S, Zarei E, Kariman H, Kazemi MK, Chehrazi M. Patient absconding and its predictors: a 5-year retrospective analysis in a general teaching Hospital in Tehran, Iran. Shiraz E-Medical Journal 2017, 18(12).
6.
Zurück zum Zitat Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L. Determinants of absconding by patients on acute psychiatric wards. J Adv Nurs. 2000;32(3):644–9.CrossRefPubMed Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L. Determinants of absconding by patients on acute psychiatric wards. J Adv Nurs. 2000;32(3):644–9.CrossRefPubMed
7.
Zurück zum Zitat Huber CG, Schneeberger AR, Kowalinski E, Fröhlich D, von Felten S, Walter M, Zinkler M, Beine K, Heinz A, Borgwardt S. Suicide risk and absconding in psychiatric hospitals with and without open door policies: a 15 year, observational study. The Lancet Psychiatry. 2016;3(9):842–9.CrossRefPubMed Huber CG, Schneeberger AR, Kowalinski E, Fröhlich D, von Felten S, Walter M, Zinkler M, Beine K, Heinz A, Borgwardt S. Suicide risk and absconding in psychiatric hospitals with and without open door policies: a 15 year, observational study. The Lancet Psychiatry. 2016;3(9):842–9.CrossRefPubMed
8.
Zurück zum Zitat Hunt IM, Windfuhr K, Swinson N, Shaw J, Appleby L, Kapur N. Suicide amongst psychiatric in-patients who abscond from the ward: a national clinical survey. BMC Psychiatry. 2010;10(1):1–6.CrossRef Hunt IM, Windfuhr K, Swinson N, Shaw J, Appleby L, Kapur N. Suicide amongst psychiatric in-patients who abscond from the ward: a national clinical survey. BMC Psychiatry. 2010;10(1):1–6.CrossRef
9.
Zurück zum Zitat Muir-Cochrane E, Mosel K, Gerace A, Esterman A, Bowers L. The profile of absconding psychiatric inpatients in Australia. J Clin Nurs. 2011;20(5–6):706–13.CrossRefPubMed Muir-Cochrane E, Mosel K, Gerace A, Esterman A, Bowers L. The profile of absconding psychiatric inpatients in Australia. J Clin Nurs. 2011;20(5–6):706–13.CrossRefPubMed
10.
Zurück zum Zitat Walsh E, Rooney S, Sloan D, McCauley P, Mulvaney F, O’Callaghan E, Larkin C. Irish psychiatric absconders: characteristics and outcome. Psychiatr Bull. 1998;22(6):351–3.CrossRef Walsh E, Rooney S, Sloan D, McCauley P, Mulvaney F, O’Callaghan E, Larkin C. Irish psychiatric absconders: characteristics and outcome. Psychiatr Bull. 1998;22(6):351–3.CrossRef
11.
Zurück zum Zitat Yasini M, Sedaghat M, Ghasemi Esfe A, Tehranidoost M. Epidemiology of absconding from an iranian psychiatric centre. J Psychiatr Ment Health Nurs. 2009;16(2):153–7.CrossRefPubMed Yasini M, Sedaghat M, Ghasemi Esfe A, Tehranidoost M. Epidemiology of absconding from an iranian psychiatric centre. J Psychiatr Ment Health Nurs. 2009;16(2):153–7.CrossRefPubMed
12.
Zurück zum Zitat Tomison AR. Characteristics of psychiatric hospital absconders. Br J Psychiatry. 1989;154(3):368–71.CrossRefPubMed Tomison AR. Characteristics of psychiatric hospital absconders. Br J Psychiatry. 1989;154(3):368–71.CrossRefPubMed
13.
Zurück zum Zitat Cabarkapa S, Sadhu R, King J, Dowling N, Radhakrishnan R, Akinbiyi A, Srinivasaraju R, Stevenson D. Profiling absconders from public and private inpatient psychiatric units: a comparative analysis. Psychiatr Q. 2020;91(2):299–307.CrossRefPubMed Cabarkapa S, Sadhu R, King J, Dowling N, Radhakrishnan R, Akinbiyi A, Srinivasaraju R, Stevenson D. Profiling absconders from public and private inpatient psychiatric units: a comparative analysis. Psychiatr Q. 2020;91(2):299–307.CrossRefPubMed
14.
Zurück zum Zitat Cullen AE, Jewell A, Tully J, Coghlan S, Dean K, Fahy T. A prospective cohort study of absconsion incidents in forensic psychiatric settings: can we identify those at high-risk? PLoS ONE. 2015;10(9):e0138819.PubMedCentralCrossRefPubMed Cullen AE, Jewell A, Tully J, Coghlan S, Dean K, Fahy T. A prospective cohort study of absconsion incidents in forensic psychiatric settings: can we identify those at high-risk? PLoS ONE. 2015;10(9):e0138819.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Kirchebner J, Lau S, Sonnweber M. Escape and absconding among offenders with schizophrenia spectrum disorder–an explorative analysis of characteristics. BMC Psychiatry. 2021;21(1):1–11.CrossRef Kirchebner J, Lau S, Sonnweber M. Escape and absconding among offenders with schizophrenia spectrum disorder–an explorative analysis of characteristics. BMC Psychiatry. 2021;21(1):1–11.CrossRef
16.
Zurück zum Zitat Khisty N, Raval N, Dhadphale M, Kale K, Javadekar A. A prospective study of patients absconding from a general hospital psychiatry unit in a developing country. J Psychiatr Ment Health Nurs. 2008;15(6):458–64.CrossRefPubMed Khisty N, Raval N, Dhadphale M, Kale K, Javadekar A. A prospective study of patients absconding from a general hospital psychiatry unit in a developing country. J Psychiatr Ment Health Nurs. 2008;15(6):458–64.CrossRefPubMed
17.
Zurück zum Zitat Karugaba M. Butabika nolonger keeps patients for long. 2014. Karugaba M. Butabika nolonger keeps patients for long. 2014.
18.
Zurück zum Zitat Kaggwa MM, Acai A, Rukundo GZ, Harms S, Ashaba S. Patients’ perspectives on the experience of absconding from a psychiatric hospital: a qualitative study. BMC Psychiatry. 2021;21(1):371.PubMedCentralCrossRefPubMed Kaggwa MM, Acai A, Rukundo GZ, Harms S, Ashaba S. Patients’ perspectives on the experience of absconding from a psychiatric hospital: a qualitative study. BMC Psychiatry. 2021;21(1):371.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Arbee F, Subramaney U. Absconding from a psychiatric hospital in Johannesburg, South Africa: are we seeing a decrease since the implementation of the Mental Healthcare Act? South Afr J psychiatry. 2019;25(1):1–6. Arbee F, Subramaney U. Absconding from a psychiatric hospital in Johannesburg, South Africa: are we seeing a decrease since the implementation of the Mental Healthcare Act? South Afr J psychiatry. 2019;25(1):1–6.
20.
Zurück zum Zitat Kaggwa MM, Rukundo GZ, Wakida EK, Maling S, Sserumaga BM, Atim LM, Obua C. Suicide and suicide attempts among patients attending primary Health Care Facilities in Uganda: A Medical Records Review. Risk Manag Healthc Policy. 2022;15:703–11.PubMedCentralCrossRefPubMed Kaggwa MM, Rukundo GZ, Wakida EK, Maling S, Sserumaga BM, Atim LM, Obua C. Suicide and suicide attempts among patients attending primary Health Care Facilities in Uganda: A Medical Records Review. Risk Manag Healthc Policy. 2022;15:703–11.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Kaggwa MM, Abaatyo J, Alol E, Muwanguzi M, Najjuka SM, Favina A, Rukundo GZ, Ashaba S, Mamun MA. Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: retrospective findings from a psychiatric ward registry. PLoS ONE. 2022;17(5):e0269044.PubMedCentralCrossRefPubMed Kaggwa MM, Abaatyo J, Alol E, Muwanguzi M, Najjuka SM, Favina A, Rukundo GZ, Ashaba S, Mamun MA. Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: retrospective findings from a psychiatric ward registry. PLoS ONE. 2022;17(5):e0269044.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Kaggwa MM, Najjuka SM, Harms S, Ashaba S. Mortality among patients admitted in a Psychiatric Facility: a single-centre review. Clin Audit. 2021;13:21–8.CrossRef Kaggwa MM, Najjuka SM, Harms S, Ashaba S. Mortality among patients admitted in a Psychiatric Facility: a single-centre review. Clin Audit. 2021;13:21–8.CrossRef
23.
Zurück zum Zitat Sheikhmoonesi F, Kabirzadeh A, Yahyavi ST, Mohseni B. A prospective study of patients absconding from a psychiatric hospital in Iran. Med Glas. 2012;9(2):345–9. Sheikhmoonesi F, Kabirzadeh A, Yahyavi ST, Mohseni B. A prospective study of patients absconding from a psychiatric hospital in Iran. Med Glas. 2012;9(2):345–9.
24.
Zurück zum Zitat Andoh B. Absconding from mental hospitals and negligence: case comment: D v South Tyneside Health care NHS trust [2004] PIQR P12. Mountbatten J Legal Stud. 2004;8(2):79–85. Andoh B. Absconding from mental hospitals and negligence: case comment: D v South Tyneside Health care NHS trust [2004] PIQR P12. Mountbatten J Legal Stud. 2004;8(2):79–85.
25.
Zurück zum Zitat Brown SM, Manuck SB, Flory JD, Hariri AR. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion. 2006;6(2):239.CrossRefPubMed Brown SM, Manuck SB, Flory JD, Hariri AR. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion. 2006;6(2):239.CrossRefPubMed
26.
Zurück zum Zitat Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh J, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis. Acta psychiatrica Scandinavica. 2013;128(3):149–62.CrossRefPubMed Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh J, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis. Acta psychiatrica Scandinavica. 2013;128(3):149–62.CrossRefPubMed
27.
Zurück zum Zitat Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, Nicastro R, Hasler R, Nallet A, Piguet C. Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety. 2016;33(1):45–55.CrossRefPubMed Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, Nicastro R, Hasler R, Nallet A, Piguet C. Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety. 2016;33(1):45–55.CrossRefPubMed
28.
Zurück zum Zitat Aas M, Henry C, Bellivier F, Lajnef M, Gard S, Kahn J-P, Lagerberg T, Aminoff S, Bjella T, Leboyer M. Affective lability mediates the association between childhood trauma and suicide attempts, mixed episodes and co-morbid anxiety disorders in bipolar disorders. Psychol Med. 2017;47(5):902–12.CrossRefPubMed Aas M, Henry C, Bellivier F, Lajnef M, Gard S, Kahn J-P, Lagerberg T, Aminoff S, Bjella T, Leboyer M. Affective lability mediates the association between childhood trauma and suicide attempts, mixed episodes and co-morbid anxiety disorders in bipolar disorders. Psychol Med. 2017;47(5):902–12.CrossRefPubMed
29.
Zurück zum Zitat Wilkie T, Penney SR, Fernane S, Simpson AIF. Characteristics and motivations of absconders from forensic mental health services: a case-control study. BMC Psychiatry. 2014;14(1):91.PubMedCentralCrossRefPubMed Wilkie T, Penney SR, Fernane S, Simpson AIF. Characteristics and motivations of absconders from forensic mental health services: a case-control study. BMC Psychiatry. 2014;14(1):91.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Battistella G, Fornari E, Annoni J-M, Chtioui H, Dao K, Fabritius M, Favrat B, Mall J-F, Maeder P, Giroud C. Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014;39(9):2041–8.PubMedCentralCrossRefPubMed Battistella G, Fornari E, Annoni J-M, Chtioui H, Dao K, Fabritius M, Favrat B, Mall J-F, Maeder P, Giroud C. Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014;39(9):2041–8.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000;2(3p2):269–80.CrossRefPubMed Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2000;2(3p2):269–80.CrossRefPubMed
32.
Zurück zum Zitat Turna J, Simpson W, Patterson B, Lucas P, Van Ameringen M. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of canadian medicinal cannabis users. J Psychiatr Res. 2019;111:134–9.CrossRefPubMed Turna J, Simpson W, Patterson B, Lucas P, Van Ameringen M. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of canadian medicinal cannabis users. J Psychiatr Res. 2019;111:134–9.CrossRefPubMed
33.
Zurück zum Zitat Kamal BS, Kamal F, Lantela DE. Cannabis and the anxiety of fragmentation—a systems approach for finding an anxiolytic cannabis chemotype. Front NeuroSci. 2018;12:730.PubMedCentralCrossRefPubMed Kamal BS, Kamal F, Lantela DE. Cannabis and the anxiety of fragmentation—a systems approach for finding an anxiolytic cannabis chemotype. Front NeuroSci. 2018;12:730.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Mangoo S, Erridge S, Holvey C, Coomber R, Barros DAR, Bhoskar U, Mwimba G, Praveen K, Symeon C, Sachdeva-Mohan S et al. Assessment of clinical outcomes of medicinal cannabis therapy for depression: Analysis from the UK Medical Cannabis Registry. Expert Rev Neurother 2022:null–null. Mangoo S, Erridge S, Holvey C, Coomber R, Barros DAR, Bhoskar U, Mwimba G, Praveen K, Symeon C, Sachdeva-Mohan S et al. Assessment of clinical outcomes of medicinal cannabis therapy for depression: Analysis from the UK Medical Cannabis Registry. Expert Rev Neurother 2022:null–null.
35.
Zurück zum Zitat Langan-Fox J, Vranic V. Intern coping, stress and patient-adverse events: the human, hospital and system’cost’of developing medical expertise. Edward Elgar Publishing; 2011. Langan-Fox J, Vranic V. Intern coping, stress and patient-adverse events: the human, hospital and system’cost’of developing medical expertise. Edward Elgar Publishing; 2011.
36.
Zurück zum Zitat Botsford SL, Yang S, George TP. Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential. Am J addictions. 2020;29(1):9–26.CrossRef Botsford SL, Yang S, George TP. Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential. Am J addictions. 2020;29(1):9–26.CrossRef
37.
Zurück zum Zitat Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord. 2015;171:39–47.CrossRefPubMed Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord. 2015;171:39–47.CrossRefPubMed
38.
Zurück zum Zitat van Rossum I, Boomsma M, Tenback D, Reed C, van Os J. Does cannabis use affect treatment outcome in bipolar disorder?: a longitudinal analysis. J Nerv Ment Dis. 2009;197(1):35–40.CrossRefPubMed van Rossum I, Boomsma M, Tenback D, Reed C, van Os J. Does cannabis use affect treatment outcome in bipolar disorder?: a longitudinal analysis. J Nerv Ment Dis. 2009;197(1):35–40.CrossRefPubMed
39.
Zurück zum Zitat Raveendran NS, Tharyan P, Alexander J, Adams CE. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ. 2007;335(7625):865.PubMedCentralCrossRefPubMed Raveendran NS, Tharyan P, Alexander J, Adams CE. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ. 2007;335(7625):865.PubMedCentralCrossRefPubMed
40.
Zurück zum Zitat Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185(1):63–9.CrossRefPubMed Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185(1):63–9.CrossRefPubMed
41.
Zurück zum Zitat Wöhr M. Measuring mania-like elevated mood through amphetamine‐induced 50‐kHz ultrasonic vocalizations in rats. Br J Pharmacol. 2022;179(17):4201–19.CrossRefPubMed Wöhr M. Measuring mania-like elevated mood through amphetamine‐induced 50‐kHz ultrasonic vocalizations in rats. Br J Pharmacol. 2022;179(17):4201–19.CrossRefPubMed
42.
Zurück zum Zitat Berk M, Dodd S, Kauer-Sant’anna M, Malhi G, Bourin M, Kapczinski F, Norman T. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta psychiatrica Scandinavica. 2007;116:41–9.CrossRef Berk M, Dodd S, Kauer-Sant’anna M, Malhi G, Bourin M, Kapczinski F, Norman T. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta psychiatrica Scandinavica. 2007;116:41–9.CrossRef
43.
Zurück zum Zitat Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disord. 2009;11(8):787–806.CrossRefPubMed Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disord. 2009;11(8):787–806.CrossRefPubMed
44.
Zurück zum Zitat Reynolds GP. Receptor mechanisms of antipsychotic drug action in bipolar disorder–focus on asenapine. Therapeutic Adv Psychopharmacol. 2011;1(6):197–204.CrossRef Reynolds GP. Receptor mechanisms of antipsychotic drug action in bipolar disorder–focus on asenapine. Therapeutic Adv Psychopharmacol. 2011;1(6):197–204.CrossRef
45.
Zurück zum Zitat Marin RS, Wilkosz PA. Disorders of diminished motivation. J Head Trauma Rehabil. 2005;20(4):377–88.CrossRefPubMed Marin RS, Wilkosz PA. Disorders of diminished motivation. J Head Trauma Rehabil. 2005;20(4):377–88.CrossRefPubMed
46.
Zurück zum Zitat Simpson MA. The phenomenology of self-mutilation in a general hospital setting. In.: SAGE Publications Sage CA: Los Angeles, CA; 1975. Simpson MA. The phenomenology of self-mutilation in a general hospital setting. In.: SAGE Publications Sage CA: Los Angeles, CA; 1975.
47.
Zurück zum Zitat Maden A, Curle C, Meux C, Burrow S, Gunn J. The treatment and security needs of patients in special hospitals. Criminal Behav Mental Health. 1993;3(4):290–306.CrossRef Maden A, Curle C, Meux C, Burrow S, Gunn J. The treatment and security needs of patients in special hospitals. Criminal Behav Mental Health. 1993;3(4):290–306.CrossRef
48.
Zurück zum Zitat Craighead WE, Craighead LW. The role of psychotherapy in treating psychiatric disorders. Med Clin North Am. 2001;85(3):617–29.CrossRefPubMed Craighead WE, Craighead LW. The role of psychotherapy in treating psychiatric disorders. Med Clin North Am. 2001;85(3):617–29.CrossRefPubMed
49.
Zurück zum Zitat Follette VM, La Bash HA, Sewell MT. Adult disclosure of a history of childhood sexual abuse: implications for behavioral psychotherapy. J Trauma Dissociation. 2010;11(2):228–43.CrossRefPubMed Follette VM, La Bash HA, Sewell MT. Adult disclosure of a history of childhood sexual abuse: implications for behavioral psychotherapy. J Trauma Dissociation. 2010;11(2):228–43.CrossRefPubMed
50.
Zurück zum Zitat Exline JJ, Pargament KI, Wilt JA, Harriott VA. Mental illness, normal psychological processes, or attacks by the devil? Three lenses to frame demonic struggles in therapy. Spiritual Clin Pract 2021. Exline JJ, Pargament KI, Wilt JA, Harriott VA. Mental illness, normal psychological processes, or attacks by the devil? Three lenses to frame demonic struggles in therapy. Spiritual Clin Pract 2021.
51.
Zurück zum Zitat Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S. Illness management and recovery: a review of the research. Psychiatric Serv. 2002;53(10):1272–84.CrossRef Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S. Illness management and recovery: a review of the research. Psychiatric Serv. 2002;53(10):1272–84.CrossRef
Metadaten
Titel
Absconding among admitted patients with bipolar affective disorder diagnosis in Uganda
verfasst von
Joan Abaatyo
Alain Favina
Mark Mohan Kaggwa
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Psychiatry / Ausgabe 1/2023
Elektronische ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-04794-w

Weitere Artikel der Ausgabe 1/2023

BMC Psychiatry 1/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.